Kevin Rouault-Pierre

Congrats @Fadimana Kaya for successfully defending your PhD today after surviving three PhD supervisors 😆 @JudeFitzgibbon @AnaRioMachin and @kevinrouault.bsky.social ! 🎊 🎉

Thank you very much to Profs @Elspeth (Beth) Payne and @Kamil R Kranc for examining Fadimana's thesis!

Hema Now: Episode 20: The Science Behind Myelodysplastic Syndromes Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes, and their implications for future care.

Thanks for the Podcast Helena Bradbury and Jonathan Sackier. We really enjoyed the discussion! #MDS #SF3B1 #VitaminB5 & #AcademicLife📻 🩸

www.emjreviews.com/hematology/p...

#RNAsky

#sciencejobs

Cannot be prouder!!! @celinephilippe.bsky.social First postdoc of the lab and first to become PI/Group Leader in the best place to study ER and Cancer in France 😁. Looking forward to your science! Truly inspiring! Congratulations and Well done Celine 👏🎉🎊 #ER #Cancer #RNAbiology

Thank you for the great discussions and the invitation! Likely one of the best view from a research institute! In the beautiful Barcelona ! Looking forward to future collaborations!

This Friday, do not miss Dr Rouault-Pierre's Invited Lecture!

💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells"

🗓️ 23 May, 12pm CEST
📍IJC Auditorium
Online at 👉 us06web.zoom.us/webinar/regi...

Great work! Well done @francescoterenzi.bsky.social

Many thanks to @hemasphere-journal.bsky.social for their help and support during the whole process!

One of our latest! We hope you enjoy! Led by @ShoshanaBurke & in collaboration with @OnimaChowdhury 🎉🎊. #MDS #SF3B1 #VitaminB5 #Leukemia

We are recruiting!! Ads now live for a Data Coordinator and 2 Research Assistants/biobankers to join a new @ludwigcancer.bsky.social - @imm.ox.ac.uk joint initiative to prevent progression from early- to advanced blood cancer. Joint posts with Adam Mead+others in Oxford Ludwig. Links below

💥Exciting new #postdoc opportunities in my lab at @cruk-mi.bsky.social i.bsky.social to study #NutrientHostMicrobiome interactions in #CancerImmunity in mice and humans. #CancerImmunology#MucosalImmunology#Microbiome

⏰Deadline: 4 April 2025
Apply👇
www.cruk.manchester.ac.uk/career/mi-24...

⏩RT

Thanks Diana!

Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients A deep understanding of the biological mechanisms driving the pathogenesis of myelodysplastic neoplasms (MDS) is essential to develop comprehensive therapeutic approaches that will benefit patient's ...

4/4
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1

onlinelibrary.wiley...

“Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change? Click on the article title to read more.

3/4
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!

onlinelibrary.wiley.com/doi/10.1002/...

MDS UK Funds Vitamin B5 Tests To Support A Clinical Trial Aiming To Relieve MDS-related Anaemia | MDS UK Patient Support Group MDS UK funds Vitamin B5 study to alleviate MDS anaemia, led by Oxford University researchers, approved by Birmingham University Cancer Trials, starting Spring 2025.

2/4
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.

mdspatientsupport.org.uk...

1/4
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!

www.jove.com...
www.science...

Exciting updates from KRP Lab! Since the start of 2025:

5th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting

Join us at #TheFrancisCrickInstitute, London, where leading experts from around the globe will discuss the latest research in microenvironment research.

Register now!

www.esh.org/conference/5...